Day: March 24, 2021
— Record Quarterly Revenues of $839.9 million Up 34.0% Year-Over-Year, Driven by Robust End Consumer Demand —— Organic RV Market Share Gains Continue, Rising to 11.5% (+90 Basis Points) on a Trailing Twelve Month Basis —— Second Quarter Gross Margin Expansion of 590 Basis Points to 18.6% —— Record Reported Diluted EPS of $2.04 Up 300.0%; Record Adjusted EPS of $2.12 Up 216.4% Over Prior Year —— Interest in the Outdoors Remains High as Evidenced by Elevated Order Backlogs and Retail Sales Growth —
EDEN PRAIRIE, Minn., March 24, 2021 (GLOBE NEWSWIRE) — Winnebago Industries, Inc. (NYSE: WGO), a leading outdoor lifestyle product manufacturer, today reported financial results for the Company’s second quarter of Fiscal 2021.
Second Quarter Fiscal 2021 ResultsRevenues for...
Peeter Kinnunen is appointed acting CEO of Klövern
Written by Customer Service on . Posted in Public Companies.
In line with what was communicated in a press release on 29 December 2020, Rutger Arnhult will leave his position as CEO on 25 March 2021. The Board of Directors has appointed Peeter Kinnunen acting CEO of Klövern. Peeter Kinnunen is Klövern’s Head of Transactions, belongs to the Executive Management and has been employed by the company since 2012.
The Board of Directors’ search process for a new CEO continues.
”Peeter Kinnunen has for many years been a very important colleague in Klövern. I am very confident that Peeter, together with the rest of the management team, will continue to run the company in the best way”, says Rutger Arnhult.
Klövern AB (publ)
For further information, please contact:Pia Gideon, Chairman of the Board, +46 76 768 00 76Lars Norrby, IR, +46 76 777 38 00, lars.norrby@klovern.se
Klövern is a real estate company...
Peeter Kinnunen utses till tillförordnad VD för Klövern
Written by Customer Service on . Posted in Public Companies.
I linje med vad som kommunicerades genom ett pressmeddelande den 29 december 2020 kommer Rutger Arnhult att lämna sin befattning som VD den 25 mars 2021. Som tillförordnad VD för Klövern har styrelsen utsett Peeter Kinnunen. Peeter Kinnunen är Klöverns Transaktionschef, tillhör bolagsledningen och har varit anställd i bolaget sedan 2012.
Styrelsens rekryteringsprocess av en ny VD fortsätter.
”Peeter Kinnunen har varit en central och mycket viktig medarbetare i Klövern under många år. Jag är utomordentligt trygg i att Peeter, tillsammans med övriga ledningen, kommer att fortsätta driva bolaget på bästa sätt”, säger Rutger Arnhult.
Klövern AB (publ)
För ytterligare information, vänligen kontakta:Pia Gideon, Styrelseordförande, 076-768 00 76Lars Norrby, IR, 076-777 38 00, lars.norrby@klovern.se
Klövern är ett fastighetsbolag som med närhet...
Final terms for bonds to be opened 26th March 2021
Written by Customer Service on . Posted in Public Companies.
To Nasdaq Copenhagen A/S 24th March 2021 Announcement no. 35/2021
Final terms for bonds to be opened 26th March 2021
On 26th March 2021, Jyske Realkredit A/S will open new covered bonds (SDO). Final terms for the bonds are attached to this announcement.
The full prospectus for the Bond consist of the attached final terms and the previously disclosed ”Base Prospectus for the issue of Covered Bonds (SDO), Mortgage bonds (“RO”) and Mortgage Bonds (RO) and bonds issued pursuant to Section 15 of the Danish Mortgage-Credit Loans and Mortgage-Credit Bonds etc. Act (Section 15 Bonds).”, dated February 23th, 2021.
Jyske Realkredit’s base prospectus is available on Jyske Realkredit’s...
Endelige vilkår for nye obligationer der åbnes den 26. marts 2021
Written by Customer Service on . Posted in Public Companies.
Til Nasdaq Copenhagen A/S 24. marts 2021 Meddelelse nr. 35/2021
Endelige vilkår for nye obligationer der åbnes den 26. marts 2021
Jyske Realkredit åbner den 26. marts 2021 en ny særligt dækkende obligation (SDO). Med denne meddelelse følger de endelige vilkår for obligationerne.
Det samlede prospekt for obligationerne består af vedlagte endelige vilkår og det tidligere offentliggjorte ”Basisprospekt for udstedelse af Særligt Dækkede Obligationer (SDO), Realkreditobligationer (RO) og obligationer i medfør af § 15 i lov om realkreditlån og realkreditobligationer m.v. (§ 15 Obligationer)”, dateret 23. februar 2021.
Jyske...
Crinetics Pharmaceuticals to Host Webcast and Conference Call to Discuss 2021 Clinical Plans and Fourth Quarter and Full Year 2020 Financial Results
Written by Customer Service on . Posted in Public Companies.
SAN DIEGO, March 24, 2021 (GLOBE NEWSWIRE) — Crinetics Pharmaceuticals, Inc. (Nasdaq: CRNX), a clinical stage pharmaceutical company focused on the discovery, development, and commercialization of novel therapeutics for rare endocrine diseases and endocrine-related tumors, today announced that it will host a webcast and conference call on Tuesday, March 30, 2021 at 4:30 p.m. ET to discuss its 2021 clinical plans and financial results for the fourth quarter and full year 2020.
To access the webcast, please visit this link to the event. To participate by phone, please dial 877-407-0789 (domestic) or 201-689-8562 (international) and refer to conference ID 13717687. Following the live event, the archived webcast will be available for 90 days.
About Crinetics PharmaceuticalsCrinetics Pharmaceuticals is a clinical stage pharmaceutical...
Emerging Markets Report: Small Wonders
Written by Customer Service on . Posted in Public Companies.
An Emerging Markets Sponsored Commentary
ORLANDO, Fla., March 24, 2021 (GLOBE NEWSWIRE) — Today’s featured Company is a little different than some of our more recent profiles. Frankly, we’ve seen nothing like it before.
Allow us to introduce KWESST Micro Systems Inc. (TSXV: KWE) (OTCQB: KWEMF), which describes itself as “a proud leader in advancing the modern networked capability of soldiers and responders, including the networked Soldier Systems mission of NATO and its allies, with niche applications that make a critical difference to safety and effectiveness.”
What really stands out about the Company’s tech is that it is all about making the science of warfare smaller and thus more efficient. This video is a must see.
Everything is centered around KWESST’s proprietary “MISST” system, which is short for “Micro...
Nubeva Closes Software Licensing Agreement with Megazone Cloud
Written by Customer Service on . Posted in Public Companies.
San Jose, California, March 24, 2021 (GLOBE NEWSWIRE) — SAN JOSE, Calif., March 23, 2021 – Nubeva Technologies Ltd. (TSX-V: NBVA), a developer of decryption software that broadens network traffic security and visibility, today announced a software license agreement with Megazone Cloud, a leading cloud-managed service provider (MSP) based in Asia. This agreement will enable Megazone to expand their Network Security product suite to answer the TLS visibility challenge in modern cloud and on-prem networks with simplified, high performance, lower cost decryption.
“We are thrilled to be working with a market leader and visionary like Megazone Cloud,” said Steve Perkins, Nubeva’s Chief Marketing Officer. “The application of our TLS visibility product, to their already leading cloud services suite, will bring back visibility and control...
Transplantation Market to Hit USD 14.67 Billion and Grow at 10.6% CAGR by 2028; Rising Prevalence of Chronic Diseases to Fuel Demand for Organ Transplantation: states Fortune Business Insights™
Written by Customer Service on . Posted in Mergers And Acquisitions.
Pune, India, March 24, 2021 (GLOBE NEWSWIRE) — The global transplantation market size is expected to reach USD 14.67 billion by 2028, exhibiting a CAGR of 10.6% during the forecast period. The rising prevalence of chronic diseases coupled with technological advancements will spur business opportunities for this market, states Fortune Business Insights, in a report, titled “Transplantation Market, 2021-2028.” The market size stood at USD 5.47 billion in 2020.
Key Development:
September 2019: CareDx announced a strategic partnership with NanoString to expand its product portfolio. Through this partnership, the company will enhance the development of molecular assays in transplantation and improve transplant diagnostics.
Request a Sample Copy of the Global Research Report:https://www.fortunebusinessinsights.com/enquiry/request-sample-pdf/transplantation-market-105049
COVID-19...
Myovant Sciences and Pfizer Announce Positive Data from Phase 3 LIBERTY Randomized Withdrawal Study of Once-Daily Relugolix Combination Therapy in Women with Uterine Fibroids
Written by Customer Service on . Posted in Public Companies.
78.4% of women who continued on relugolix combination therapy remained responders (menstrual blood loss < 80 mL) through Week 76 compared with 15.1% of women who discontinued treatment at Week 52 (p < 0.0001)
69.8% of women who continued relugolix combination therapy remained responders through Week 104
88.3% of women who discontinued treatment relapsed with heavy menstrual bleeding, on average 5.9 weeks after discontinuation
Myovant to host conference call and webcast today at 8:30 a.m. Eastern Time / 5:30 a.m. Pacific TimeBASEL, Switzerland and NEW YORK, March 24, 2021 (GLOBE NEWSWIRE) — Myovant Sciences (NYSE: MYOV) and Pfizer Inc. (NYSE: PFE) today announced positive data from the Phase 3 LIBERTY randomized withdrawal study of relugolix combination therapy (relugolix 40 mg plus estradiol 1.0 mg and norethindrone acetate 0.5...